NASDAQ Acquisition: $JUPW acquires the assets of Applied Biology Inc., a leading biotechnology company specializing in hair and skin science: Jupiter Wellness, Inc. (NASDAQ: JUPW)

Taisho introduces a minoxidil booster developed by Applied Biology to boost the effectiveness of minoxidil in patients with androgenetic alopecia who are unresponsive to minoxidil

Minoxidil sulfotransferase enzyme booster (SULT1A1) was acquired by Jupiter Wellness in an asset acquisition comprising issued patents, patent applications, products, clinical trial results and license agreements of Applied Biology

Check out Jupiter Wellness, Inc. (NASDAQ: JUPW) at to see why it’s undervalued

JUPW Applied Biology generated approximately $8 million in revenue and $3 million in EBITDA in 2021

– JUPW has been featured on CNN, ABC, CBS, Bloomberg, Vogue and Forbes.

– JW-300 treatment Demonstrated effectiveness in developing burns (sunburn) in a clinical trial.

– Acquisition of Ascent Clinical Research adding $3 million in annual revenue plus contribution to EBITDA.

– JUPW buys and withdraws 2,433,894 common shares

Recent news:

JUPW announces the acquisition of 100% of the assets of Applied Biology, Inc., a leading biotechnology company specializing in hair and skin science, for up to 4 million shares of Jupiter Wellness deliverable to the completion of certain steps.

Applied Biology is a developer of breakthrough drugs and medical devices for the treatment of skin and hair disorders. Led by the top thought leaders in their fields, the company’s new pharmaceutical R&D pipeline focuses on hair and skin conditions as well as women’s health and COVID-19.

Acquisition Highlights

Expected to Accelerate Revenue and Earnings Growth: With the potential to add up to $8 million in revenue and $3 million in EBITDA on an annualized basis (based on unaudited financial data from 2021)

Acceleration and Expansion of Development Pipeline: The acquisition expands Jupiter Wellness’ pipeline to other dermatology drugs in various stages of clinical and preclinical development.

Marketed products:

Photocil – Jupiter Wellness obtains worldwide rights to patented Photocil, a new topical treatment for psoriasis, vitiligo, pruritus and atopic dermatitis. Jupiter Wellness previously licensed exclusive marketing rights.

Minoxidil Booster – Minoxidil Booster dramatically improves the effectiveness of minoxidil (by 30% to 60%+) by enhancing the generation of minoxidil sulfate, the active drug.

Adds a strong area of ​​intellectual property: Applied Biology’s intellectual property portfolio includes 35 patent applications and three issued U.S. patents for:

Photocil: methods and compositions for delivering specific wavelength phototherapy

COVID-19 and the treatment of respiratory infections: systems, methods and kits for the diagnosis and treatment of viral respiratory infections

Women’s Health: Treatment of Sexual Dysfunction

About JUPW:

Jupiter Wellness, Inc. (NASDAQ: JUPW) is a leading developer of cannabidiol (CBD) therapeutic and medical wellness products. The JUPW clinical pipeline of prescription CBD-enhanced skin care therapeutics addresses indications such as eczema, burns, herpetic cold sores, and skin cancer.

JUPW will offer clinical research services with the acquisition of Ascent Clinical Research: $3 million in annual revenue and contribution to EBITDA

On April 27, JUPW announced that it had entered into an asset purchase agreement with Ascent Clinical Research, Inc. whereby it acquired certain clinical assets, including clinical trial research contracts worth $3 million. dollars in annual revenue for a purchase price of 5% future net revenue royalties. generated by assets.

JUPW Launches Patent-Pending Formula-Backed NoStingz Jellyfish Protective Sunscreen Into $13 Billion Sunscreen Market

On April 5, JUPW announced the launch of NoStingz, an exclusive line of sunscreens and signed a licensing agreement with Shark Defense Technologies for exclusive worldwide intellectual property rights.

On February 18, JUPW announced that it had completed enrollment in its clinical trial of JW-200 for the treatment of actinic keratosis (AK).

JUPW Board of Directors Approves $5.0 Million Share Repurchase Program

On January 25, JUPW announced that its board of directors had approved a $5.0 million stock repurchase program that expires on June 30, 2022. Under the stock repurchase program, common stock of JUPW may be repurchased periodically on the open market or in privately negotiated transactions.

For more information, visit (JUPW) at:

**All products mentioned in this article are THC-free and Farm Bill 2018 compliant**

DISCLAIMER: This article is for informational purposes only and does not constitute a recommendation to buy or sell stocks.

Media Contact

Organization: Jupiter Wellness, Inc.

Contact person: Brian John

E-mail: Send an email

Country: United States


Post Acquisition NASDAQ: $JUPW Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Sciences: Jupiter Wellness, Inc. (NASDAQ: JUPW) appeared first on King Newswire.

The information on this page is provided by an independent third party content provider. Binary News Network and this site make no warranties or representations in this regard. If you are affiliated with this page and would like it removed, please contact [email protected]